000 01247 a2200349 4500
005 20250516154623.0
264 0 _c20140207
008 201402s 0 0 eng d
022 _a1873-2518
024 7 _a10.1016/j.vaccine.2013.05.051
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aWhitney, Cynthia G
245 0 0 _aWhat do policy makers need to know? Lessons from the decision to add pneumococcal conjugate and rotavirus vaccines to the US immunization program.
_h[electronic resource]
260 _bVaccine
_cJul 2013
300 _aC6-7 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAdvisory Committees
650 0 4 _aCenters for Disease Control and Prevention, U.S.
650 0 4 _aCost-Benefit Analysis
650 0 4 _aDecision Making
650 0 4 _aEvidence-Based Practice
650 0 4 _aHealth Policy
650 0 4 _aHumans
650 0 4 _aImmunization Programs
_xeconomics
650 0 4 _aPneumococcal Vaccines
650 0 4 _aRotavirus Vaccines
650 0 4 _aUnited States
650 0 4 _aVaccines, Conjugate
700 1 _aParashar, Umesh D
773 0 _tVaccine
_gvol. 31 Suppl 3
_gp. C6-7
856 4 0 _uhttps://doi.org/10.1016/j.vaccine.2013.05.051
_zAvailable from publisher's website
999 _c22846609
_d22846609